JP2025509853A5 - - Google Patents
Info
- Publication number
- JP2025509853A5 JP2025509853A5 JP2024555386A JP2024555386A JP2025509853A5 JP 2025509853 A5 JP2025509853 A5 JP 2025509853A5 JP 2024555386 A JP2024555386 A JP 2024555386A JP 2024555386 A JP2024555386 A JP 2024555386A JP 2025509853 A5 JP2025509853 A5 JP 2025509853A5
- Authority
- JP
- Japan
- Prior art keywords
- zinc finger
- finger domain
- amino acid
- hybrid
- cys2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2031325 | 2022-03-18 | ||
| NL2031325A NL2031325B1 (en) | 2022-03-18 | 2022-03-18 | Novel zinc finger degron sequences |
| PCT/NL2023/050136 WO2023177296A1 (en) | 2022-03-18 | 2023-03-17 | Zinc finger degron sequences |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509853A JP2025509853A (ja) | 2025-04-11 |
| JP2025509853A5 true JP2025509853A5 (https=) | 2026-02-25 |
Family
ID=82483007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024555386A Pending JP2025509853A (ja) | 2022-03-18 | 2023-03-17 | ジンクフィンガーデグロン配列 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250206789A1 (https=) |
| EP (1) | EP4493696A1 (https=) |
| JP (1) | JP2025509853A (https=) |
| CN (1) | CN118922547A (https=) |
| AU (1) | AU2023233426A1 (https=) |
| CA (1) | CA3255620A1 (https=) |
| IL (1) | IL315649A (https=) |
| NL (1) | NL2031325B1 (https=) |
| WO (1) | WO2023177296A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL2033636B1 (en) | 2022-11-29 | 2024-06-04 | Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis | Receptor- and drug-dependent regulated on-site production of biologicals. |
| NL2037809B1 (en) | 2024-05-29 | 2025-12-12 | Cell Control Biotherapeutics Inc | Loop reinforcement expression system for improved cell therapy products |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201710620D0 (en) | 2017-07-03 | 2017-08-16 | Glaxosmithkline Intellectual Property Ltd | Targeted protein degradation |
| US12049482B2 (en) | 2017-10-31 | 2024-07-30 | The Brigham And Women's Hospital, Inc. | Molecular switch-mediated control of engineered cells |
| WO2020132039A2 (en) | 2018-12-18 | 2020-06-25 | Dana-Farber Cancer Institute, Inc. | Peptide tags for ligand induced degradation of fusion proteins |
| CN111907552B (zh) | 2019-07-17 | 2021-08-13 | 中车大同电力机车有限公司 | 机车牵引装置及其调整方法 |
| EP4048301B1 (en) | 2019-10-23 | 2024-09-18 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Chimeric polypeptide for regulating immune cells |
| US20230151342A1 (en) | 2020-02-28 | 2023-05-18 | The Broad Institute, Inc | Zinc finger degradation domains |
-
2022
- 2022-03-18 NL NL2031325A patent/NL2031325B1/en not_active IP Right Cessation
-
2023
- 2023-03-17 CA CA3255620A patent/CA3255620A1/en active Pending
- 2023-03-17 IL IL315649A patent/IL315649A/en unknown
- 2023-03-17 US US18/845,540 patent/US20250206789A1/en active Pending
- 2023-03-17 JP JP2024555386A patent/JP2025509853A/ja active Pending
- 2023-03-17 EP EP23714358.1A patent/EP4493696A1/en active Pending
- 2023-03-17 WO PCT/NL2023/050136 patent/WO2023177296A1/en not_active Ceased
- 2023-03-17 AU AU2023233426A patent/AU2023233426A1/en active Pending
- 2023-03-17 CN CN202380027768.5A patent/CN118922547A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025509853A5 (https=) | ||
| ES3001108T3 (es) | Moléculas quiméricas y usos de las mismas | |
| PH12020551039A1 (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| JP2015525217A5 (https=) | ||
| JP2010519251A5 (https=) | ||
| DE60035517D1 (de) | Gl50 moleküle, sowie verwendungen derselben | |
| JP2011525363A5 (https=) | ||
| JP2014503198A5 (https=) | ||
| KR101647804B1 (ko) | 신규 세포투과 펩타이드 및 이의 용도 | |
| RU2019104948A (ru) | Генетически модифицированные бактерии, стабильно экспрессирующие ил-10 и инсулин | |
| JP2011505850A5 (https=) | ||
| JP2017538443A5 (https=) | ||
| MD3286209T2 (ro) | Metodă de producere a gonadotrofinei | |
| MX2009004985A (es) | Secuencias para activar la expresión y control de las modificaciones de post-traducción de un polipéptido recombinante. | |
| Moriguchi et al. | Structure and subcellular localization of a small RNA‐binding protein from tobacco | |
| Xi et al. | Molecular assembly of recombinant chicken type II collagen in the yeast Pichia pastoris | |
| JP2017524366A5 (https=) | ||
| JP2022536122A5 (https=) | ||
| Katz et al. | Green fluorescent protein labeling of cytoskeletal structures—Novel targeting approach based on leucine zippers | |
| CN110760541A (zh) | 用中国仓鼠卵巢细胞表达外源蛋白时信号肽的选择方法及应用 | |
| ES2560012T3 (es) | Métodos y composiciones farmacéuticas para el tratamiento de enfermedades autoinmunitarias | |
| RU2017104284A (ru) | Выделенные полипептиды cd44 и их применение | |
| JP5450985B2 (ja) | 真核細胞において組換えタンパク質を細胞外に放出させるためのポリヌクレオチド | |
| JP2020505056A5 (https=) | ||
| CN103060334A (zh) | 家蚕PABP结合蛋白互作因子基因BmPaip1及其重组表达载体和应用 |